Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand

Intern Med J. 2003 Jul;33(7):310-3. doi: 10.1046/j.1445-5994.2003.00401.x.

Abstract

Both the gaseous and the particulate phases of tobacco and cannabis smoke contain a similar range of harmful chemicals. However, differing patterns of inhalation mean that smoking a 'joint' of cannabis results in exposure to significantly greater amounts of combusted material than with a tobacco cigarette. The histopathological effects of cannabis smoke exposure include changes consistent with acute and chronic bronchitis. Cellular dysplasia has also been observed, suggesting that, like tobacco smoke, cannabis exposure has the potential to cause malignancy. These features are consistent with the clinical presentation. Symptoms of cough and early morning sputum production are common (20-25%) even in young individuals who smoke cannabis alone. Almost all studies indicate that the effects of cannabis and tobacco smoking are additive and independent. Public health education should dispel the myth that cannabis smoking is relatively safe by highlighting that the adverse respiratory effects of smoking cannabis are similar to those of smoking tobacco, even although it remains to be confirmed that smoking cannabis alone leads to the development of chronic lung disease.

Publication types

  • Comparative Study
  • Guideline
  • Practice Guideline

MeSH terms

  • Australia
  • Biopsy, Needle
  • Female
  • Health Education / standards
  • Health Planning Guidelines
  • Humans
  • Immunohistochemistry
  • Lung Diseases / chemically induced*
  • Male
  • Marijuana Smoking / adverse effects*
  • Particle Size
  • Respiration Disorders / chemically induced*
  • Respiratory Function Tests
  • Severity of Illness Index
  • Time Factors
  • Tobacco Use Disorder / diagnosis*